Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
Reported health problems – including at least four deaths – not listed on the safety label of the implantable permanent birth control Essure have prompted the Food and Drug Administration (FDA) to conduct an investigation into the safety of the devices. Essure is a nonsurgical permanent birth control implant shaped in a spiral that is inserted through the cervix and through the uterus into the fallopian tubes to block fertilization. Bayer Healthcare’s unit Conceptus Inc., received FDA approval to market the device in 2002. Since then, nearly 5,100 reports of complications have been associated with the device, including four deaths. ... Read More
Attorneys for six women suing Johnson & Johnson over injuries they claim to have suffered after undergoing gynecological procedures with the company’s power morcellator device have filed a request with the U.S. Judicial Panel on Multidistrict Litigation to consolidate with at least 22 similar lawsuits pending in 16 different federal district courts. The motion seeks to transfer the cases to U.S. District Judge Kathryn Vratil in Kansas. The request comes just weeks after the Wall Street Journal reported that Johnson & Johnson was being investigated by the Federal Bureau of Investigation (FBI) about how much the company knew about cancer ... Read More
Medtronic is recalling tracheostomy tubes for neonatal and pediatric patients after 12 serious patient injury reports. The tubes, used during tracheostomy procedures to help provide an airway and facilitate the ability to breathe, were formed with a wider-angle bend than standard models, which have caused complications in patients including breathing difficulties that impacted oxygen levels or discomfort. The affected devices include eight product lines of Medtronic Covidien Shiley tracheostomy tubes manufactured after Nov. 29, 2012. Medtronic has informed hospitals and distributors worldwide of the recall and instructed them to notify the primary care physician and the homecare provider that the ... Read More
A law firm is going head-to-head with the Food and Drug Administration (FDA) over documents the agency refused to make public about specific side effects in children taking the antipsychotic drug Risperdal. Sheller PC claims it was stifled in its efforts to advocate on behalf of children injured by Risperdal when it was barred from turning over to the FDA confidential documents it had obtained through discovery in litigation against the makers of the drug. The firm petitioned the FDA in November to change the safety labels on Risperdal and revoke its pediatric indication because of reports that the drug caused ... Read More
A Redmond, Ore., physician could lose her license and be fined thousand of dollars for a long list of violations including prescribing unnecessary and excessive testosterone treatments to a man who developed side effects. The Oregon Medical Review Board’s report claims Dr. Rose Kenny, a family practice physician at a Family Care Center was “grossly negligent” in her treatment of patients. In one case, she over prescribed narcotics to a truck driver who reported having six alcoholic drinks per day. She also prescribed excessive and contraindicated medication to treat diaper rash, and doled out several months of antibiotics to pediatric ... Read More
Plaintiffs in more than 500 lawsuits spread across two separate multidistrict litigations alleging defectively designed transvaginal mesh made by Bard Inc. and Ethicon Inc. caused serious injuries have requested their cases be moved out of West Virginia and into Pennsylvania federal court so that their claims could be dealt with faster. More than 70,000 lawsuits in seven separate multidistrict litigations alleging injuries with transvaginal mesh from various manufacturers are pending in West Virginia. At least 23,000 of those are waged against Johnson & Johnson’s Ethicon, and another 10,000 have been filed against Bard. This week, U.S. District Judge Joseph Goodwin, ... Read More
Danish drug company Novo Nordisk has become the top seller of diabetes medications thanks to its blockbuster type 2 diabetes treatment Victoza (liraglutide), which brought in a whopping $2 billion in sales, up 15 percent over last year. Novo Nordisk displaced Sanofi, which sells numerous insulin products including Lantus, insulin-delivery devices as well as the diabetes drugs Lyxumia (lixisenatide) and Amaryl/Amarel (glimepiride). Victoza was approved by the Food and Drug Administration (FDA) in 2010 and became one of the newer members of a new class of diabetes medications known as incretin mimetics. Other drugs in this class include Byetta/Bydureon (exenatide) ... Read More
Twenty-six lawsuits in a massive multidistrict against Johnson & Johnson unit Ethicon, Inc., alleging the company sold defectively designed transvaginal mesh resulting in serious injuries will be consolidated and go to trial, a West Virginia federal judge ruled. The lawsuits are among about 23,000 filed against Ethicon over transvaginal mesh that will likely go to trial in November. The 26 all involve West Virginia plaintiffs who underwent procedures in the state to have Ethicon’s mesh implanted for the treatment of pelvic organ prolapse or stress urinary incontinence. Thus, all 26 lawsuits are subject to the state’s relevant laws. After the ... Read More
Adults with schizophrenia and caregivers of adults with schizophrenia are frustrated with medications to treat the condition because the side effects are hard to deal with, according to a survey conducted by Harris Poll on behalf of Otsuka America Pharmaeutical, Inc. and Lundbeck. The Living with Schizophrenia survey involved 120 adults (ages 18+) with schizophrenia, 300 unpaid caregivers of adults with schizophrenia, and 151 psychiatrists who treat adults with schizophrenia. “Schizophrenia is a serious, progressive disease that has a significant impact on patients and caregivers. When it comes to treating it, both groups have been making concessions in an effort ... Read More
Medical device manufacturer Zimmer is recalling one of its femoral stem and neck components used in hip replacement surgeries because higher than expected levels of manufacturing residues were left on the devices. These residues may cause patients to experience allergic reactions, pain, infections or death, and revision surgery may be needed to replace the defective devices. The recall involves the Zimmer M/L Taper with Kinectiv Technology Femoral Stems and Necks, which are Tivanium alloy implants that allow the surgeon to fit the implant specifically to the patient. During hip replacement surgery, the damaged portions of the hip joint are removed ... Read More